Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research
Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies. Kits are expected in early 2027. The post Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research appeared first on GEN - Genetic Engineering and Biotechnology News .
Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies. Kits are expected in early 2027. The post Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research appeared first on GEN - Genetic Engineering and Biotechnology News .
This is a summary of the story. Read the full article at GEN — Genetic Engineering & Biotechnology News ↗